DOCSLIB.ORG

The Molecular Virology and Reverse Genetics of Influenza C Virus

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Molecular Virology and Reverse Genetics of Influenza C Virus Jpn. J. Infect. Dis., 63, 157­165, 2010 Review The Molecular Virology and Reverse Genetics of Influenza C Virus Yasushi Muraki1,2* and Seiji Hongo2 1Department of Microbiology, Kanazawa Medical University School of Medicine, Ishikawa 920­0293; and 2Department of Infectious Diseases, Yamagata University Faculty of Medicine, Yamagata 990­9585, Japan (Received January 18, 2010. Accepted March 29, 2010) CONTENTS 1. Introduction 6. Analysis of the structure­function relationship of 2. Reverse genetics of influenza viruses the M1 protein 3. Molecular virology of influenza C virus 7. Comparison of the generation efficiencies of in­ 4. Epidemiology of influenza C virus fluenza C and A viruses 5. Generation of influenza C virus­like particles and a 8. Prospects for research on influenza C virology recombinant influenza C virus 9. Conclusion SUMMARY: Influenza C virus, an enveloped virus containing seven single­stranded RNA segments of negative polarity, belongs to the genus Influenza C Virus of the family Orthomyxoviridae. A number of questions remain to be resolved with regard to the molecular virology and epidemiology of the virus. To address them, we have established a virus­like particle (VLP) generation system and reverse genetics of the virus and succeeded in clarifying the structure­function relationship of the M1 protein of the virus. Although the approach adopted was similar to that for influenza A virus reverse genetics, the number of infectious influenza C viruses generated was much lower than that for influenza A virus. Based on a comparison of the number of influenza C VLPs with that of influenza A VLPs generated using a similar system, we proposed a virion generation mechanism unique to influenza C virus. for the generation of negative­sense RNA viruses, re­ 1. Introduction searchersfacedtheobstacleofprovidingtheviral Reverse genetics, as the term is used in molecular RNA (vRNA) with viral RNA polymerase and nucleo­ virology, describes the generation of viruses possessing protein. In the case of influenza A virus, the viral genome(s) derived from cloned cDNA(s). Of the viruses ribonucleoprotein (vRNP) complex, composed of belonging to the family Orthomyxoviridae,reverse three polymerase subunits (PB2, PB1, and PA), genetics has hitherto been reported for influenza A, in­ nucleoprotein (NP) and vRNA, is minimally required. fluenza B and Thogoto viruses. Recently, our research Initially, by transfecting an artificially reconstituted group, as well as Crescenzo­Chaigne and van der Werf, vRNP complex into eukaryotic cells followed by infec­ reported the successful reverse genetics of influenza C tion with an influenza helper virus, successful recovery virus. of a recombinant influenza virus containing a viral gene In this review, we will first provide an overview of segment derived from the cloned cDNA was reported research on reverse genetics of influenza A virus, and (1,2). then summarize the molecular virology and epidemiolo­ In 1996, Pleschka et al. reported the successful gener­ gy of influenza C virus, including a discussion of ation of a transfectant influenza virus (3). To synthesize presently unresolved issues of the virus. In the latter influenza vRNA in the nucleus, they made use of a part of this review, we will deal with a virus­like particle nucleolar enzyme, RNA polymerase I, in a system that (VLP) generation and reverse genetics of influenza C vi­ had been established by Zobel et al. (4). Cotransfection rus by our research group and provide a hypothesis to of the Pol Iplasmid encoding neuraminidase (NA) explain influenza C virion generation as observed in the vRNA together with viral protein­expressing plasmids established reverse­genetics system. for PB2, PB1, PA, and NP, followed by infection with an influenza helper virus, resulted in the recovery of a recombinant containing the NA gene of interest. Even 2. Reverse genetics of influenzaviruses in using this method, however, the helper virus­depen­ The genomes of negative­sense RNA viruses, includ­ dent system remained an obstacle to the efficient recov­ ing influenza viruses, are noninfectious. Therefore, ery of the recombinant virus. In 1999, a recombinant influenza A virus was report­ ed to be generated entirely from cloned cDNA for the *Corresponding author: Mailing address: Department of first time (5). The cDNAs of the eight vRNA segments Microbiology, Kanazawa Medical University School of of A/WSN/33 or A/PR/8/34 virus were each cloned Medicine, Uchinada, Ishikawa 920­0293, Japan. Tel: {81­ into the pHH21 vector in negative­sense orientation be­ 76­218­8097, Fax: {81­76­286­3961, E­mail: ymuraki tween the RNA polymerase Ipromoter and terminator kanazawa­med.ac.jp sequences. The resulting eight plasmids were transfected 157 into 293T cells together with four (PB2, PB1, PA, and virus. Yamashita et al. cloned the three largest RNA NP) or nine (PB2, PB1, PA, HA, NP, NA, M1, M2, segments of C/JJ/50 (17). A comparison of the nucleo­ and NS2) viral protein­expressing plasmid DNAs. tide sequences of the segments with those of the influen­ Despite the need for the simultaneous transfection of as za A and B viruses revealed that RNA segments 1 and 2 many as 12 or 17 plasmids into the cells, approximately encode the proteins equivalent to PB2 and PB1 of the 106 to 107 infectious influenza A viruses/mL were pro­ influenza A and B viruses, respectively. The protein en­ duced at 48 to 72 h posttransfection. Thus, a recom­ coded by RNA segment 3 is referred to as P3 rather than binant influenza A virus in which all RNA segments PA, since it does not display any acid charge features at were derived from cDNA clones was generated. a neutral pH. Evidence has been obtained to suggest Improved approaches for the generation of the re­ that the transcription and replication of the influenza C combinant influenza A virus were later reported by virus genome follows the same strategy as that of in­ several research groups (68). Furthermore, influenza B fluenza A virus in that the three proteins form an RNA (911) and Thogoto viruses (12) were successfully gener­ ated in a similar way. Despite all these advances, however, no reverse genetics of influenza C virus was es­ tablished. 3. Molecular virology of influenza C virus Influenza C virus, which belongs to the genus In­ fluenza C Virus of the family Orthomyxoviridae,was first isolated from a patient with respiratory illness in 1947 (13). It is an enveloped virus containing seven sin­ gle­stranded RNA segments of negative polarity and en­ codes the following proteins: PB2, PB1, P3, hemag­ glutinin­esterase­fusion (HEF), NP, matrix (M1) pro­ tein, and CM2, as well as the non­structural proteins Fig. 1. Structure of influenza C virus. Influenza C virus has NS1 and NS2 (Figs. 1 and 2). The virus usually causes seven single­stranded RNA segments of negative polarity. The mild upper respiratory illness (14), but it can also cause viral ribonucleoprotein (vRNP) complex is composed of viral RNA (vRNA) and the PB2, PB1, P3, and NP proteins. HEF lower respiratory infections (15,16). forms a spike on the virion. M1 is present beneath the enve­ A number of research groups have studied the struc­ lope. CM2 is the second membrane protein of the virus. A ture and function of the genes and gene products of the small amount of NS2 is incorporated into the virions. Fig. 2. Genome structure of influenza C/Ann Arbor/1/50 virus. RNA segments 1 (PB2 gene) to 7 (NS gene) are shown in positive­sense orientation. Numbers indicate the nucleotide positions along the genes. The lines at the 5? and 3? termini represent the noncoding regions. The V­shaped dotted lines in segments 6 and 7 indicate the intron. Viral proteins encoded by the genes are shown in boxes with the number of amino acids in parentheses. M1 is en­ coded by a spliced mRNA of RNA segment 6 (M gene), into which the TGA (stop codon) is introduced as a result of splicing. The P42 protein, encoded by a collinear transcript of the M gene, is cleaved by signal peptidase at an internal cleavage site (black triangle) to generate M1' and CM2. RNA segment 7 (NS gene) encodes the NS1 and NS2 proteins. NS1 is encoded by a collinear mRNA, and NS2 is encoded by a spliced mRNA. The C­terminal region of NS2 (gray area) contains {1 ORF. The C/Ann Arbor/1/50 strain contains a total of 12,906 nucleotides. 158 polymerase complex (1820), although the precise the 374­amino­acid protein, P42, which is cleaved by role(s) of the respective proteins remains to be elucidat­ signal peptidase at an internal cleavage site to give M1' ed. and CM2 (43,44). The biochemical features of CM2, the RNA segment 4 encodes the HEF glycoprotein, which second membrane protein of the virus, are closely simi­ forms a spike on the virus envelope (Fig. 1). The HEF lar to those of M2 (45,46), a proton channel of influenza protein has three biological activities: receptor binding, A virus. Although CM2 expressed in Xenopus laevis oo­ receptor destroying (acetylesterase), and membrane cytes forms an ion channel permeable to Cl| (47) and fusing activities. The receptor of the virus is the 9­O­ CM2 has the ability to modulate the pH of the exocytic acetyl­N­acetylneuraminic acid (Neu5,9Ac2), and the pathway (48), the role of CM2 in the virus replication acetylesterase activity of HEF inactivates the virus cycle remains unclear. M1', composed of the N­terminal receptor by releasing the O­acetyl residues from the C­9 259aminoacidsofP42,isdegradedshortlyafter position of Neu5,9Ac2 (2123). The fusion activity of cleavage through the signal located in the C­terminal 17­ HEF is dependent on the proteolytic cleavage of a amino acid region of the protein (49).
Load more

Recommended publications
  • Direct Agroinoculation of Maize Seedlings by Injection with Recombinant Foxtail Mosaic Virus and Sugarcane Mosaic Virus Infectious Clones
    Direct Agroinoculation of Maize Seedlings by Injection with Recombinant Foxtail Mosaic Virus and Sugarcane Mosaic Virus Infectious Clones Bliss M. Beernink*,1, Katerina L. Holan*,1, Ryan R. Lappe1, Steven A. Whitham1 1 Department of Plant Pathology and Microbiology, Iowa State University * These authors contributed equally Corresponding Author Abstract Steven A. Whitham [email protected] Agrobacterium-based inoculation approaches are widely used for introducing viral vectors into plant tissues. This study details a protocol for the injection of maize Citation seedlings near meristematic tissue with Agrobacterium carrying a viral vector. Beernink, B.M., Holan, K.L., Lappe, R.R., Recombinant foxtail mosaic virus (FoMV) clones engineered for gene silencing and Whitham, S.A. Direct Agroinoculation of Maize Seedlings by Injection with gene expression were used to optimize this method, and its use was expanded Recombinant Foxtail Mosaic Virus and to include a recombinant sugarcane mosaic virus (SCMV) engineered for gene Sugarcane Mosaic Virus Infectious Clones. J. Vis. Exp. (168), e62277, expression. Gene fragments or coding sequences of interest are inserted into a doi:10.3791/62277 (2021). modified, infectious viral genome that has been cloned into the binary T-DNA plasmid vector pCAMBIA1380. The resulting plasmid constructs are transformed into Date Published Agrobacterium tumefaciens strain GV3101. Maize seedlings as young as 4 days February 27, 2021 old can be injected near the coleoptilar node with bacteria resuspended in MgSO4 DOI
    [Show full text]
  • Influenza Virus Infections in Humans October 2018
    Influenza virus infections in humans October 2018 This note is provided in order to clarify the differences among seasonal influenza, pandemic influenza, and zoonotic or variant influenza. Seasonal influenza Seasonal influenza viruses circulate and cause disease in humans every year. In temperate climates, disease tends to occur seasonally in the winter months, spreading from person-to- person through sneezing, coughing, or touching contaminated surfaces. Seasonal influenza viruses can cause mild to severe illness and even death, particularly in some high-risk individuals. Persons at increased risk for severe disease include pregnant women, the very young and very old, immune-compromised people, and people with chronic underlying medical conditions. Seasonal influenza viruses evolve continuously, which means that people can get infected multiple times throughout their lives. Therefore the components of seasonal influenza vaccines are reviewed frequently (currently biannually) and updated periodically to ensure continued effectiveness of the vaccines. There are three large groupings or types of seasonal influenza viruses, labeled A, B, and C. Type A influenza viruses are further divided into subtypes according to the specific variety and combinations of two proteins that occur on the surface of the virus, the hemagglutinin or “H” protein and the neuraminidase or “N” protein. Currently, influenza A(H1N1) and A(H3N2) are the circulating seasonal influenza A virus subtypes. This seasonal A(H1N1) virus is the same virus that caused the 2009 influenza pandemic, as it is now circulating seasonally. In addition, there are two type B viruses that are also circulating as seasonal influenza viruses, which are named after the areas where they were first identified, Victoria lineage and Yamagata lineage.
    [Show full text]
  • Use of Cell Culture in Virology for Developing Countries in the South-East Asia Region © World Health Organization 2017
    USE OF CELL C USE OF CELL U LT U RE IN VIROLOGY FOR DE RE IN VIROLOGY V ELOPING C O U NTRIES IN THE NTRIES IN S O U TH- E AST USE OF CELL CULTURE A SIA IN VIROLOGY FOR R EGION ISBN: 978-92-9022-600-0 DEVELOPING COUNTRIES IN THE SOUTH-EAST ASIA REGION World Health House Indraprastha Estate, Mahatma Gandhi Marg, New Delhi-110002, India Website: www.searo.who.int USE OF CELL CULTURE IN VIROLOGY FOR DEVELOPING COUNTRIES IN THE SOUTH-EAST ASIA REGION © World Health Organization 2017 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial- ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition.” Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.
    [Show full text]
  • Chapter 14: Functional Genomics Learning Objectives
    Chapter 14: Functional Genomics Learning objectives Upon reading this chapter, you should be able to: ■ define functional genomics; ■ describe the key features of eight model organisms; ■ explain techniques of forward and reverse genetics; ■ discuss the relation between the central dogma and functional genomics; and ■ describe proteomics-based approaches to functional genomics. Outline : Functional genomics Introduction Relation between genotype and phenotype Eight model organisms E. coli; yeast; Arabidopsis; C. elegans; Drosophila; zebrafish; mouse; human Functional genomics using reverse and forward genetics Reverse genetics: mouse knockouts; yeast; gene trapping; insertional mutatgenesis; gene silencing Forward genetics: chemical mutagenesis Functional genomics and the central dogma Approaches to function; Functional genomics and DNA; …and RNA; …and protein Proteomic approaches to functional genomics CASP; protein-protein interactions; protein networks Perspective Albert Blakeslee (1874–1954) studied the effect of altered chromosome numbers on the phenotype of the jimson-weed Datura stramonium, a flowering plant. Introduction: Functional genomics Functional genomics is the genome-wide study of the function of DNA (including both genes and non-genic regions), as well as RNA and proteins encoded by DNA. The term “functional genomics” may apply to • the genome, transcriptome, or proteome • the use of high-throughput screens • the perturbation of gene function • the complex relationship of genotype and phenotype Functional genomics approaches to high throughput analyses Relationship between genotype and phenotype The genotype of an individual consists of the DNA that comprises the organism. The phenotype is the outward manifestation in terms of properties such as size, shape, movement, and physiology. We can consider the phenotype of a cell (e.g., a precursor cell may develop into a brain cell or liver cell) or the phenotype of an organism (e.g., a person may have a disease phenotype such as sickle‐cell anemia).
    [Show full text]
  • Epidemiology and Clinical Characteristics of Influenza C Virus
    viruses Review Epidemiology and Clinical Characteristics of Influenza C Virus Bethany K. Sederdahl 1 and John V. Williams 1,2,* 1 Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA; [email protected] 2 Institute for Infection, Inflammation, and Immunity in Children (i4Kids), University of Pittsburgh, Pittsburgh, PA 15224, USA * Correspondence: [email protected] Received: 30 December 2019; Accepted: 7 January 2020; Published: 13 January 2020 Abstract: Influenza C virus (ICV) is a common yet under-recognized cause of acute respiratory illness. ICV seropositivity has been found to be as high as 90% by 7–10 years of age, suggesting that most people are exposed to ICV at least once during childhood. Due to difficulty detecting ICV by cell culture, epidemiologic studies of ICV likely have underestimated the burden of ICV infection and disease. Recent development of highly sensitive RT-PCR has facilitated epidemiologic studies that provide further insights into the prevalence, seasonality, and course of ICV infection. In this review, we summarize the epidemiology and clinical characteristics of ICV. Keywords: orthomyxoviruses; influenza C; epidemiology 1. Introduction Influenza C virus (ICV) is lesser known type of influenza virus that commonly causes cold-like symptoms and sometimes causes lower respiratory infection, especially in children <2 years of age [1]. ICV is mainly a human pathogen; however, the virus has been detected in pigs, dogs, and cattle, and rare swine–human transmission has been reported [2–6]. ICV seropositivity has been found to be as high as 90% by 7–10 years of age, suggesting that most people are exposed to influenza C virus at least once during childhood [7,8].
    [Show full text]
  • Isolation of Influenza C Virus During the 1 999/2000 - Influenza Season in Hiroshima Prefecture, Japan
    Jpn. J. Infect. Dis., 53, 2000 Laboratory and Epidemiology Communications Isolation of Influenza C Virus during the 1 999/2000 - Influenza Season in Hiroshima Prefecture, Japan Shinichi Takao*, Yoko MatsuzakiI , Yukie Shimazu, Shinji Fukuda, Masahiro Noda and Shizuyo Tbkumoto Division of Microbiology II, Hiroshima Prefectural Institute of Health and EnviylDnment, Minami-machi Il6-29, Minami-ku, Hiroshima 734-0007 and JDepartment ofBacleriology, Yamagata UniversiOJ School of Medicine, Iida-Nishi 2-2-2, Yamagata 990-9585 Communicated by Hiroo lnouye (Accepted August 16, 2000) Althoughinfluenza C virus is considered to be an etiological Vimses were isolated by uslng MDCK cells andノor 7-day- agent formi1d upper respiratory illness in humans (1), it ca.n old embryonated hen's eggs (Table). In MDCK cells, the also?ause lower resplratOry tract infection (2)･ Seroepidem1- viruses produced only weak cytopathic effects sand grew very 010glCal studies have revealed that the virus is prevalent slowly. Several passages were necessary to attain a hemag- worldwide and that infection occurs at an early stage in life (3,4)･ Howe.ver･ there is little information regarding its epidemiologlCal and clinical features because the virus has only occasionally been isolated (2,5,6). According to the Infectious Agents Surveillance Report in Japan, while 5,699 innueTza A(HIN 1 )virus isolates, 12,822 innuenzaA(H3N2) virus isolates and 5,232 influenza B virus isolates were reported in 1991-1996 in Japan, only 18 isolates ofinnuenza C virus were reported during the same period (7). In this paper, We report eight isolated cases of influenza C virus from the 1 999/2000 - influenza season in Hiroshima Prefecture, Japan.
    [Show full text]
  • Recombinant and Chimeric Viruses
    Recombinant and chimeric viruses: Evaluation of risks associated with changes in tropism Ben P.H. Peeters Animal Sciences Group, Wageningen University and Research Centre, Division of Infectious Diseases, P.O. Box 65, 8200 AB Lelystad, The Netherlands. May 2005 This report represents the personal opinion of the author. The interpretation of the data presented in this report is the sole responsibility of the author and does not necessarily represent the opinion of COGEM or the Animal Sciences Group. Dit rapport is op persoonlijke titel door de auteur samengesteld. De interpretatie van de gepresenteerde gegevens komt geheel voor rekening van de auteur en representeert niet de mening van de COGEM, noch die van de Animal Sciences Group. Advisory Committee Prof. dr. R.C. Hoeben (Chairman) Leiden University Medical Centre Dr. D. van Zaane Wageningen University and Research Centre Dr. C. van Maanen Animal Health Service Drs. D. Louz Bureau Genetically Modified Organisms Ing. A.M.P van Beurden Commission on Genetic Modification Recombinant and chimeric viruses 2 INHOUDSOPGAVE RECOMBINANT AND CHIMERIC VIRUSES: EVALUATION OF RISKS ASSOCIATED WITH CHANGES IN TROPISM Executive summary............................................................................................................................... 5 Introduction............................................................................................................................................ 7 1. Genetic modification of viruses .................................................................................................9
    [Show full text]
  • Call to Action: the Dangers of Influenza and COVID-19 in Adults
    Call to Action The Dangers of Influenza and COVID-19 in Adults with Chronic Health Conditions October 2020 Experts urge all healthcare professionals to prioritize influenza vaccination to help protect adults with chronic health conditions during the COVID-19 pandemic The recommendations in this Call to Action are based on discussions from an Call to Action August 2020 Roundtable convened by the National Foundation for Infectious The Dangers of Influenza Diseases (NFID). The multidisciplinary and COVID-19 in Adults with group of subject matter experts Chronic Health Conditions explored the risks of co-circulation and co-infection with influenza and SARS-CoV-2 viruses in adults with chronic Overview health conditions from the perspective While every influenza (flu) season is unpredictable, of their specialized areas of medicine the 2020-2021 season is characterized by an and discussed strategies to protect unprecedented dual threat: co-circulation of these vulnerable populations. influenza and the novel coronavirus (SARS-CoV-2) that causes COVID-19. Moreover, there is concern Experts agreed that higher levels of that co-circulation and co-infection with influenza influenza vaccination coverage during and COVID-19 viruses could be especially harmful, the 2020-2021 influenza season could particularly among adults at increased risk of reduce the number of influenza-related influenza-related complications. hospitalizations, helping to avoid Influenza poses serious health risks to adults unnecessary strain on the US healthcare with certain chronic health conditions including system during the COVID-19 pandemic, heart disease, lung disease, and diabetes. The so that healthcare facilities have the increased risk of influenza-related complications capacity to provide care to patients includes the potential exacerbation of underlying with COVID-19.
    [Show full text]
  • Technical Glossary
    WBVGL 6/28/03 12:00 AM Page 409 Technical Glossary abortive infection: Infection of a cell where there is no net increase in the production of infectious virus. abortive transformation: See transitory (transient or abortive) transformation. acid blob activator: A regulatory protein that acts in trans to alter gene expression and whose activity depends on a region of an amino acid sequence containing acidic or phosphorylated residues. acquired immune deficiency syndrome (AIDS): A disease characterized by loss of cell-mediated and humoral immunity as the result of infection with human immunodeficiency virus (HIV). acute infection: An infection marked by a sudden onset of detectable symptoms usually followed by complete or apparent recovery. adaptive immunity (acquired immunity): See immunity. adjuvant: Something added to a drug to increase the effectiveness of that drug. With respect to the immune system, an adjuvant increases the response of the system to a particular antigen. agnogene: A region of a genome that contains an open reading frame of unknown function; origi- nally used to describe a 67- to 71-amino acid product from the late region of SV40. AIDS: See acquired immune deficiency syndrome. aliquot: One of a number of replicate samples of known size. a-TIF: The alpha trans-inducing factor protein of HSV; a structural (virion) protein that functions as an acid blob transcriptional activator. Its specificity requires interaction with certain host cel- lular proteins (such as Oct1) that bind to immediate-early promoter enhancers. ambisense genome: An RNA genome that contains sequence information in both the positive and negative senses. The S genomic segment of the Arenaviridae and of certain genera of the Bunyaviridae have this characteristic.
    [Show full text]
  • Virus Goes Viral: an Educational Kit for Virology Classes
    Souza et al. Virology Journal (2020) 17:13 https://doi.org/10.1186/s12985-020-1291-9 RESEARCH Open Access Virus goes viral: an educational kit for virology classes Gabriel Augusto Pires de Souza1†, Victória Fulgêncio Queiroz1†, Maurício Teixeira Lima1†, Erik Vinicius de Sousa Reis1, Luiz Felipe Leomil Coelho2 and Jônatas Santos Abrahão1* Abstract Background: Viruses are the most numerous entities on Earth and have also been central to many episodes in the history of humankind. As the study of viruses progresses further and further, there are several limitations in transferring this knowledge to undergraduate and high school students. This deficiency is due to the difficulty in designing hands-on lessons that allow students to better absorb content, given limited financial resources and facilities, as well as the difficulty of exploiting viral particles, due to their small dimensions. The development of tools for teaching virology is important to encourage educators to expand on the covered topics and connect them to recent findings. Discoveries, such as giant DNA viruses, have provided an opportunity to explore aspects of viral particles in ways never seen before. Coupling these novel findings with techniques already explored by classical virology, including visualization of cytopathic effects on permissive cells, may represent a new way for teaching virology. This work aimed to develop a slide microscope kit that explores giant virus particles and some aspects of animal virus interaction with cell lines, with the goal of providing an innovative approach to virology teaching. Methods: Slides were produced by staining, with crystal violet, purified giant viruses and BSC-40 and Vero cells infected with viruses of the genera Orthopoxvirus, Flavivirus, and Alphavirus.
    [Show full text]
  • Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
    Review Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines Ekramy E. Sayedahmed 1 , Ahmed Elkashif 1, Marwa Alhashimi 1, Suryaprakash Sambhara 2,* and Suresh K. Mittal 1,* 1 Department of Comparative Pathobiology, Purdue Institute for Immunology, Inflammation and Infectious Disease, Purdue University Center for Cancer Research, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907, USA; [email protected] (E.E.S.); [email protected] (A.E.); [email protected] (M.A.) 2 Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA * Correspondence: [email protected] (S.S.); [email protected] (S.K.M.) Received: 2 August 2020; Accepted: 17 September 2020; Published: 1 October 2020 Abstract: Ever since the discovery of vaccines, many deadly diseases have been contained worldwide, ultimately culminating in the eradication of smallpox and polio, which represented significant medical achievements in human health. However, this does not account for the threat influenza poses on public health. The currently licensed seasonal influenza vaccines primarily confer excellent strain-specific protection. In addition to the seasonal influenza viruses, the emergence and spread of avian influenza pandemic viruses such as H5N1, H7N9, H7N7, and H9N2 to humans have highlighted the urgent need to adopt a new global preparedness for an influenza pandemic. It is vital to explore new strategies for the development of effective vaccines for pandemic and seasonal influenza viruses. The new vaccine approaches should provide durable and broad protection with the capability of large-scale vaccine production within a short time. The adenoviral (Ad) vector-based vaccine platform offers a robust egg-independent production system for manufacturing large numbers of influenza vaccines inexpensively in a short timeframe.
    [Show full text]
  • Bronchiolitis
    Bronchiolitis What is bronchiolitis? Bronchiolitis is a viral infection of the lungs that usually affects infants. There is swelling in the smaller airways or bronchioles of the lung, which causes coughing and wheezing. Bronchiolitis is the most common reason for children under 1 year old to be admitted to the hospital. What are the symptoms of bronchiolitis? The following are the most common symptoms of bronchiolitis. However, each child may experience symptoms differently. Symptoms may include: Runny nose or nasal congestion Fever Cough Changes in breathing patterns (wheezing and breathing faster or harder are common) Decreased appetite Fussiness Vomiting What causes bronchiolitis? Bronchiolitis is a common illness caused by different viruses. The most common virus causing this infection is Respiratory Syncytial Virus (RSV). However, many other viruses can cause bronchiolitis including: Influenza, Parainfluenza, Rhinovirus, Adenovirus, and Human metapneumovirus. Initially, the virus causes an infection in the upper airways, and then spreads downward into the lower airways of the lungs. The virus causes swelling of the airways. Mucus is also produced in the airways. This narrowing of the airways can make it difficult for your child to breath, eat, or nurse. How is bronchiolitis diagnosed? Bronchiolitis is usually diagnosed on the history and physical examination of the child. Antibiotics are not helpful in treating viruses and are not needed to treat bronchiolitis. Because there is no cure for the disease, the goal of treatment is to make your child comfortable and to support their symptoms. This treatment may include suctioning to keep the airways clear, extra oxygen if the blood oxygen levels are low, or hydration if your child is not able to feed well.
    [Show full text]